Millennium Pharmaceuticals to Acquire COR Therapeutics in $2.0 Billion Deal

Millennium Pharmaceuticals to Acquire COR Therapeutics in $2.0 Billion Deal

News

On December 6, 2001, Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) announced that it had signed a definitive agreement to acquire COR Therapeutics, Inc. (Nasdaq: CORR) in a stock-for-stock exchange valued at $2.0 billion.

Millennium was advised by the following Hale and Dorr lawyers: